Renal Insufficiency, Chronic: all 3,224 studies
Page 29 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.
- Barriers to Peritoneal Dialysis SelectionCompletedNCT01517841
- Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01509716
- Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis PatientsStatus unknownNCT01509690Phase 2/3
- Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis PatientsStatus unknownNCT01509027Not applicable
- Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic HaemodialysisCompletedNCT01502137Phase 1
- A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01500798Phase 1
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsCompletedNCT01487109Phase 2
- Efficacy and Safety Study to Delay Renal Failure in Children With Alport SyndromeCompletedNCT01485978Phase 3
- Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I TreatmentCompletedNCT01485900Phase 1
- Enhancing Dialysis Adequacy: Effects of Intradialytic ExerciseStatus unknownNCT01481688Phase 4
- Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)Status unknownNCT01479088Phase 2/3
- A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney DiseaseCompletedNCT01475760Not applicable
- Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis StudyCompletedNCT01475747
- Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)CompletedNCT01469078Phase 1
- Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)WithdrawnNCT01468506
- The Effect of Citrasate Dialysate on Heparin Dose in HemodialysisCompletedNCT01466959Not applicable
- A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.CompletedNCT01464320Phase 1
- Red Blood Cell LifespanTerminatedNCT01462071
- Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney DiseaseCompletedNCT01460199Phase 1
- Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRDCompletedNCT01459770Not applicable
- Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis PatientsCompletedNCT01458808Phase 4
- Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney DiseaseStatus unknownNCT01458158
- Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)WithdrawnNCT01453634Phase 2
- Renal Transplantation and Raltegravir in HIV-Infected PatientsCompletedNCT01453192Phase 3
- A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney DiseaseStatus unknownNCT01452360
- Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on DialysisCompletedNCT01450709
- Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric PatientsCompletedNCT01447485Phase 1
- Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)CompletedNCT01446029Phase 3
- Renal Nerve Ablation in Chronic Kidney Disease PatientsCompletedNCT01442883
- Providing Resources to Enhance African American Patients' Readiness to Make Decisions About Kidney Disease (PREPARED) StudyCompletedNCT01439516Not applicable
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney DiseaseWithdrawnNCT01428154Phase 1
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney DiseaseWithdrawnNCT01426724Not applicable
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With AtrasentanCompletedNCT01424319Phase 2
- Association Between Urine Concentration Ability and the Progression of Chronic Kidney DiseaseStatus unknownNCT01423045
- Renal Sympathetic Modification in Patients With Chronic Renal FailureStatus unknownNCT01418560Not applicable
- Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease (CKD)- ELPD StudyStatus unknownNCT01418508Not applicable
- Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD)Status unknownNCT01415570
- The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft BypassStatus unknownNCT01410617Phase 2/3
- Evaluation of Fructose Ingestion and the Renin Angiotensin System in HumansCompletedNCT01407627Not applicable
- Comparison of Markers of Kidney FunctionCompletedNCT01403766
- Web-based Interactive Health Communication Application (IHCA) for Successful Home DialysisStatus unknownNCT01403454Not applicable
- Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk PatientsTerminatedNCT01402219Phase 4
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyCompletedNCT01399580Phase 2
- Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) PatientsCompletedNCT01399489Not applicable
- Pentraxin-3 in Chronic Renal FailureCompletedNCT01397773
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast AgentWithdrawnNCT01391520Phase 3
- Aspirin Response in High Risk Patients With Coronary Artery DiseaseStatus unknownNCT01383304
- Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis PatientsStatus unknownNCT01382966
- Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)CompletedNCT01380717Phase 4
- Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)Status unknownNCT01377285Phase 4
- Depressed Cardiac Autonomic Modulation in Patients With Chronic Kidney Disease Diagnosed by Spectral AnalysisCompletedNCT01376635
- Prevalence of Aspirin Resistance in Chronic Kidney Disease PatientsCompletedNCT01364779
- Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney DiseaseStatus unknownNCT01364688Phase 2
- Prevention of Contrast Induced Nephropathy by ErythropoietinStatus unknownNCT01364402Phase 3
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney DiseaseCompletedNCT01363336
- Endotoxin, Neutrophil Function and Albumin in Renal InsufficiencyCompletedNCT01362569
- Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus RestrictionStatus unknownNCT01357317Phase 3
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorCompletedNCT01356849Phase 2
- Weight Loss Improves Renal HemodynamicsCompletedNCT01356394Phase 4
- Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionCompletedNCT01353417
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 DiabetesTerminatedNCT01351675Phase 3
- Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis PatientsCompletedNCT01351636Phase 4
- Pulmonary Hypertension Prevention in HemodialysisStatus unknownNCT01350687
- Inspiratory Muscle Training in Patients With End Stage Renal FailureStatus unknownNCT01347775Phase 4
- Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal FailureStatus unknownNCT01346215Phase 3
- BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney DiseaseCompletedNCT01345656Phase 2
- Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 SubjectsWithdrawnNCT01343641Phase 2
- Trial of an Internet-based Platform for Managing Chronic Diseases at a DistanceCompletedNCT01342263Not applicable
- Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD)CompletedNCT01341691Early Phase 1
- Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney DiseaseCompletedNCT01341678Not applicable
- FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).Status unknownNCT01332526
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney DiseaseCompletedNCT01328470Phase 4
- Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth HormoneCompletedNCT01327924
- The Incretin Effect in Patients With Kidney ImpairmentCompletedNCT01327378
- Vitamin D Effect on Calcium Absorption on Persons on HemodialysisCompletedNCT01325610Not applicable
- Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD PatientsCompletedNCT01324193Not applicable
- Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)Status unknownNCT01323712Phase 2/3
- PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing GumCompletedNCT01319578Not applicable
- HepZero:Heparin Free Dialysis With EvodialCompletedNCT01318486Not applicable
- The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney DiseaseStatus unknownNCT01317186
- Factors Related to the Progression of Chronic Kidney DiseaseStatus unknownNCT01317173
- Salivary Phosphorus and Level of Kidney FunctionCompletedNCT01311973
- An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or DialysisCompletedNCT01309295
- Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseCompletedNCT01308242Early Phase 1
- A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney DiseaseCompletedNCT01305824Phase 2
- Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis PatientsCompletedNCT01305317Not applicable
- Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) PatientsWithdrawnNCT01302236Phase 4
- The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) PatientsStatus unknownNCT01298869
- Patient INformation About Options for Treatment - PINOTCompletedNCT01298115
- Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney DiseaseWithdrawnNCT01294904
- Serum Magnesium and Vascular CalcificationCompletedNCT01293786
- Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney DiseaseCompletedNCT01291888
- Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCompletedNCT01282762
- Evaluation of Electrostimulation Program During Dialysis Sessions in Chronic Renal Failure PatientsCompletedNCT01282554Not applicable
- Aortic Stiffness in Chronic Kidney Disease Stage 2 to 4CompletedNCT01279460
- Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4TerminatedNCT01277497Phase 4
- Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant CandidatesCompletedNCT01261910Not applicable
- Atorvastatin and Sympathetic Activity in Chronic Kidney DiseaseCompletedNCT01257009Phase 4